1660-5527
Bimonthly
No
SKIN PHARMACOL PHYS
2004
34
UNITED STATES
http://www.karger.com/Journal/Home/224194
>12周,或约稿审稿时间
3区中科院分区
较易平均录用比例
3.2影响因子
皮肤病学小学科
22/96JIF RANK
2265总被引频次
在过去的十年里,皮肤药理学的研究有了很大的发展,新的和有前途的药物和治疗概念被定期引入。最近的例子包括免疫抑制剂,以及治疗恶性黑色素瘤和伤口愈合的新战略。在传统的皮肤治疗和护肤领域也有了新的概念,这些概念导致了诸如美国的“宇宙性”、日本的“准药物”等问题的讨论。欧盟化妆品条例第6修正案。有许多悬而未决的问题反映了这一主题的重要性和建立一个新的国际科学论坛的必要性,以便能够对这些问题进行详尽的讨论。邀请皮肤科医生、药物化学家、药理学家、毒理学家和其他对这一课题感兴趣的人为这一激动人心的项目作出贡献,并提交他们最好的研究成果供出版。
http://www.karger.com/Journal/Guidelines/224194
In the past decade research into skin pharmacology has developed dramatically with new and promising drugs and therapeutic concepts being introduced regularly. Recent examples include immunosuppressive topicals, and new strategies in the therapy of malignant melanoma and wound healing. New concepts have also been developed in traditional areas of skin therapy and skin care which have led to discussions of issues such as ‘cosmeceuticals’ in the United States, ‘quasi-drugs’ in Japan, and the 6th Amendment of the Cosmetic Regulation in the European Union. There are many open questions which reflect the importance of the subject and the need for a new international scientific forum where they can be discussed in extenso. Dermatologists, pharmaceutical chemists, pharmacologists, toxicologists, and others interested in the subject are invited to contribute to this exciting project and to submit their best research work for publication.
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 4区 | DERMATOLOGY 皮肤病学 PHARMACOLOGY & PHARMACY 药学 | 3区 4区 | 否 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q2 | DERMATOLOGY | Q2 | 3.014 |
PHARMACOLOGY & PHARMACY | Q3 |
CiteScore | SJR | SNIP | 学科类别 | 分区 | 排名 | 百分位 |
6.40 | 0.860 | 1.549 | 大类:Medicine 小类:Dermatology | Q1 | 13 / 126 |
90% |
大类:Medicine 小类:Pharmacology | Q2 | 90 / 303 |
70% |
|||
大类:Medicine 小类:Physiology | Q2 | 56 / 180 |
69% |
影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
3.014 | 68 | 11.93% | 90.00% | 未开放 | >12周,或约稿 |